NVCT insider buying
4 cluster buysNuvectis Pharma, Inc. · Healthcare
When two or more insiders at Nuvectis Pharma, Inc. buy NVCT in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in NVCT plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Jun 30 – Jun 30, 2026Detected Jul 1, 2026Executive buyer2 insidersTotal bought$1.2MMarket cap$524.9M
- Oct 23 – Nov 5, 2025Detected Nov 5, 2025Executive buyer4 insidersTotal bought$1.1MMarket cap$618.9M
- Nov 15, 2024 – Jun 20, 2025Detected Jun 20, 2025Executive buyer4 insidersTotal bought$2.1MMarket cap$618.9M
1 more cluster in NVCT
Choose Basic for full history, or Pro for email and Telegram alerts after new insider clusters are detected. Both plans start with a 7-day trial.
All notable open-market buys in NVCT
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jun 30, 2026 | Mosseri Marlio Charlescluster 10% Owner | 50,000 | $18.32 | $916.0K | SEC ↗ |
| Jun 30, 2026 | BENTSUR RONcluster Director, Chairman & CEO, 10% Owner | 12,500 | $20.00 | $250.0K | SEC ↗ |
| Nov 5, 2025 | Sanchez Juancluster Director | 13,000 | $5.79 | $75.3K | SEC ↗ |
| Nov 5, 2025 | Kaplan Matthew L.cluster Director | 11,000 | $5.84 | $64.2K | SEC ↗ |
| Nov 5, 2025 | BENTSUR RONcluster Director, Chairman & CEO, 10% Owner | 5,000 | $5.72 | $28.6K | SEC ↗ |
| Oct 27, 2025 | Mosseri Marlio Charlescluster 10% Owner | 72,836 | $6.28 | $457.4K | SEC ↗ |
| Oct 24, 2025 | Mosseri Marlio Charlescluster 10% Owner | 35,034 | $6.15 | $215.5K | SEC ↗ |
| Oct 23, 2025 | Mosseri Marlio Charlescluster 10% Owner | 46,900 | $6.06 | $284.2K | SEC ↗ |
| Jun 20, 2025 | Mosseri Marlio Charlescluster 10% Owner | 5,603 | $7.99 | $44.8K | SEC ↗ |
| Jun 18, 2025 | Mosseri Marlio Charlescluster 10% Owner | 28,043 | $8.05 | $225.7K | SEC ↗ |
| May 12, 2025 | Mosseri Marlio Charlescluster 10% Owner | 21,167 | $8.11 | $171.7K | SEC ↗ |
| May 8, 2025 | Mosseri Marlio Charlescluster 10% Owner | 2,400 | $8.65 | $20.8K | SEC ↗ |
| May 8, 2025 | Mosseri Marlio Charlescluster 10% Owner | 100 | $8.65 | $865.0 | SEC ↗ |
| May 8, 2025 | Mosseri Marlio Charlescluster 10% Owner | 100 | $8.65 | $865.0 | SEC ↗ |
| May 8, 2025 | Mosseri Marlio Charlescluster 10% Owner | 50 | $8.65 | $432.5 | SEC ↗ |
| May 7, 2025 | Mosseri Marlio Charlescluster 10% Owner | 9,614 | $8.64 | $83.1K | SEC ↗ |
| May 7, 2025 | Mosseri Marlio Charlescluster 10% Owner | 2,703 | $8.40 | $22.7K | SEC ↗ |
| May 6, 2025 | Mosseri Marlio Charlescluster 10% Owner | 10,104 | $8.64 | $87.3K | SEC ↗ |
| May 6, 2025 | Mosseri Marlio Charlescluster 10% Owner | 2,340 | $8.40 | $19.7K | SEC ↗ |
| Feb 7, 2025 | Mosseri Marlio Charlescluster 10% Owner | 240,000 | $5.00 | $1.2M | SEC ↗ |
| Dec 24, 2024 | BENTSUR RONcluster Director, Chairman & CEO, 10% Owner | 4,500 | $4.65 | $20.9K | SEC ↗ |
| Dec 13, 2024 | Mosseri Marlio Charlescluster 10% Owner | 17,000 | $4.70 | $79.9K | SEC ↗ |
| Nov 19, 2024 | Poradosu Enriquecluster Chief Science & Business Off | 2,000 | $4.99 | $10.0K | SEC ↗ |
| Nov 15, 2024 | BENTSUR RONcluster Director, Chairman & CEO, 10% Owner | 20,000 | $4.92 | $98.4K | SEC ↗ |
| May 14, 2024 | BENTSUR RONcluster Director, Chairman & CEO, 10% Owner | 1,940 | $6.74 | $13.1K | SEC ↗ |
More Healthcare stocks with insider cluster buys
NVCT insider buying — FAQ
- Are insiders buying NVCT stock?
- Yes — 8 distinct insiders have bought NVCT (Nuvectis Pharma, Inc.) on the open market, including 4 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Jul 1, 2026.
- How much NVCT stock have insiders bought?
- Insiders have bought a combined $4.4M of NVCT across 28 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in NVCT?
- A cluster buy is two or more distinct Nuvectis Pharma, Inc. insiders — officers, directors, or 10% owners — each buying NVCT on the open market within a rolling window. NVCT has 4 detected cluster buys to date.
- Where does this NVCT insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in NVCT
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy NVCT within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding NVCT.